In brief — the direct answer
Amniocentesis is a sterile diagnostic sampling procedure performed during pregnancy to obtain a small amount of amniotic fluid. Unlike screening tests such as NIPT or NT, laboratory analysis of the sample can diagnose the conditions covered by the selected test. The scope and certainty of the result depend on the clinical question, laboratory method, sample quality, and interpretation; no single test excludes every genetic condition.
What is Amniocentesis?
During amniocentesis, a fine needle is passed through the mother's abdomen into a suitable pocket of amniotic fluid while the operator monitors the needle and fetus continuously with ultrasound. A small amount of fluid is withdrawn for the laboratory. Depending on the indication and counselling, testing may include rapid analysis for common trisomies, karyotype or chromosomal microarray, a targeted molecular test, or tests for selected fetal infections. Each method has a defined scope and limitations.
Who is at risk?
Amniocentesis is typically offered when there is a specific clinical reason to seek a definitive answer. You may be offered this procedure if:
- Screening results indicate a high risk: Such as an increased Nuchal Translucency or a high-risk NIPT result.
- A structural anomaly is found: During the 20-week anomaly scan or a fetal echocardiogram.
- Family History: You or your partner are known carriers of a specific genetic condition.
- Advanced Maternal Age: While not a requirement, some older parents choose the certainty of diagnostic testing over the probabilities of screening.
While the idea of a needle procedure can be frightening, it is important to remember that most women who undergo amniocentesis receive 'normal' results, providing them with the highest possible level of reassurance for the remainder of their pregnancy.
How we diagnose it
Amniocentesis is generally performed from 15 or 16 weeks onwards. The team first checks fetal and placental position and identifies a suitable fluid pocket, cleans the skin, and performs the sampling under continuous ultrasound guidance. Rapid QF-PCR can test for selected common trisomies and sex-chromosome conditions, while karyotype or chromosomal microarray examines a different range of chromosome changes. The laboratory confirms the expected turnaround time and the limits of the selected test.
What does management involve?
After the procedure, we advise 24–48 hours of 'relative rest'—avoiding heavy lifting or strenuous exercise. Most women return to normal activities quickly.
If the result is Normal, you can return to routine obstetric care with a massive reduction in anxiety. If the result is Abnormal, our management shifts to an integrated support model:
- Genetic Counseling: You will meet with our consultants to understand exactly what the genetic finding means for your baby's health and development.
- Specialized Care Coordination: For conditions that involve physical health issues, we begin planning for delivery in a tertiary neonatal setting with appropriate specialists.
- Emotional Support: Receiving a difficult diagnosis is a life-changing event. We provide a compassionate, judgment-free environment to discuss your options and support your family's decisions.
What are the outcomes?
Miscarriage and other complications are uncommon, but the additional procedure-related risk is not zero and estimates vary with the population, indication, operator, and study method. Your consultant will explain the estimate relevant to your situation, along with the possibility of test failure, an uncertain finding, or a result that does not answer the original clinical question. When a diagnosis is made, the result can support counselling, pregnancy care, delivery planning, and neonatal preparation.
When to see a subspecialist
Referral for amniocentesis commonly follows a high-chance screening result, a fetal structural finding, or a known familial condition. Because the appropriate laboratory test and its turnaround time depend on the clinical question, early specialist review is useful. The consultation should cover alternatives, expected scope, limitations, possible results, and procedure-related risks before consent.
Questions to ask your doctor
References & Clinical Guidelines
- ISUOG Practice Guidelines: invasive procedures for prenatal diagnosis
- Amniocentesis and Chorionic Villus Sampling (Green-top Guideline No. 8)
- Prenatal Diagnostic Testing for Genetic Disorders (Practice Bulletin 162)
